Nebojsa Slobodan Stanković

Title: Nebojsa Slobodan Stanković: Innovator in Poly(ADP-ribose) Polymerase Inhibitors

Introduction

Nebojsa Slobodan Stanković is a notable inventor based in La Jolla, California. He has made significant contributions to the field of medicinal chemistry, particularly in the development of inhibitors for poly(ADP-ribose) polymerases. His innovative work has the potential to impact cancer treatment and other therapeutic areas.

Latest Patents

Stanković holds a patent for a method of preparing poly(ADP-ribose) polymerase inhibitors. This invention relates to a new and convergent route to small molecule inhibitors, such as 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one. The method involves a key Sonogashira coupling reaction and a CuI-promoted indole formation, showcasing his expertise in synthetic chemistry.

Career Highlights

Throughout his career, Stanković has worked with prominent organizations, including Cancer Research Technology Limited and Agouron Pharmaceuticals, Inc. His experience in these companies has allowed him to collaborate with leading scientists and contribute to groundbreaking research in cancer therapeutics.

Collaborations

Some of his notable coworkers include Naresh Nayyar and Chunrong Ma. Their collaborative efforts have further advanced the research and development of innovative therapeutic solutions.

Conclusion

Nebojsa Slobodan Stanković is a distinguished inventor whose work in poly(ADP-ribose) polymerase inhibitors exemplifies the intersection of innovation and medicine. His contributions continue to pave the way for advancements in cancer treatment and beyond.